Need answers or support?  Call 866-228-4673

NATURAL SUBSTANCE STUDIED FOR FUTURE TREATMENT OF POSSIBLY INCURABLE CHILDHOOD CANCER

Tuesday, January 14, 2014
Medical Express
Released January 13, 2014

In a recent doctoral thesis submitted at Karlstad University, Christina Fjæraa Alfredsson shows how the substance ellagic acid found in red berries and nuts, for instance, can stop cell division in cultivated cells from the childhood cancer neuroblastoma and induce cell death.

In their laboratory experiments Christina Fjæraa Alfredsson and her colleagues have studied  how ellagic affects the growth and survival of cultivated . An important discovery was that adding ellagic acid resulted in a so-called programmed .  

"The number of tumour in our model system was drastically reduced after the addition of ellagic acid. The effect was dose dependent, so at the rate of reduced cell growth and cell adhesion, and thus less potential for growth, the number of cell deaths increased considerably," says Christina Fjæraa Alfredsson.

Research on cancer treatment

The results are expected to form the basis for further research on ellagic acid and the possibility to use the substance in the future as a complement to current treatments of neuroblastoma and other forms of cancer.

"Many years of research remain before we know if ellagic acid can be used clinically," says Christina Fjæraa Alfredsson.

Strong antioxidant for use in future medicinal products

Ellagic acid is a naturally occurring substance and belongs to the group of phytochemicals, which are substances that can be extracted from plants. Pomegranates, raspberries, strawberries, and walnuts are rich in ellagic acid. Ellagic acid and similar substances are mostly known as strong antioxidants and therefore potentially effective against various diseases, but today researchers are also interested in how ellagic acid can be used in future medicinal products for treating cancer, for example.

The third most common childhood cancer disease

Neuroblastoma is the third most common type in children under the age of one. Aggressive neuroblastoma is a difficult cancer type to treat, and in spite of intensive research, the death rate for this type of neuroblastoma is still very high compared with other cancer types. It is therefore crucial to develop complementary alternatives to the current methods of treatment. 

Original Article: http://medicalxpress.com/news/2014-01-natural-substance-future-treatment-possibly.html

Share/Save

©2009 Children's Brain Tumor Foundation.    274 Madison Avenue Suite 1004 New York, NY 10016    (866) 228-4673    info@cbtf.org

Privacy Policy   |   Site Map
 

X
Loading